title: Perception on adverse drug reaction reporting by physicians working in southern romania.
abstract: OBJECTIVE
  The purpose of our study was to investigate and to assess the perceptions of Romanian doctors towards adverse drug reactions (ADRs) reporting.
  
  
  METHODS
  A questionnaire with 20 items accompanied by a letter presenting the study was circulated using Internet and face to face interviews to 532 doctors in Bucharest and two neighboring regions from Romania (Muntenia and Oltenia).
  
  
  RESULTS
  204 (56.2%) of the total number of responders expressed their opinion that the daily number of ADRs observed to be under 5 309 (58%) of responders were never informed about ADRs reporting, 439 (82.52%) did not know that the Romanian College of Physicians is scoring this activity under the "Continuous medical education program". Factors that might encourage voluntary reporting of adverse reactions were identified to be: the easiness of reporting, their periodic information and the training about all adverse reactions reported by doctors and the measures taken. Factors discouraging voluntary reporting of an adverse drug reaction were: the lack of information on where, when and how to report ADRs, the uncertain causality.
  
  
  CONCLUSIONS
  Currently, the pharmacovigilance activities including reporting of ADRs in Romania are more of an accidental nature, doctors are less or not at all informed about this activity. Doctors have a favorable attitude towards reporting ADRs - as the majority believes that the reporting should be either voluntary or mandatory as opposed to a small number that would expect to be paid for this activity.
authors.affiliation: "Titu Maiorescu" University, Faculty of Medicine and Dentistry, Bucharest, Romania.
authors.forename: Marian Sorin
authors.initials: MS
authors.lastname: Paveliu
authors.forename: Simona
authors.initials: S
authors.lastname: Bengea-Luculescu
authors.forename: Mihai
authors.initials: M
authors.lastname: Toma
authors.forename: Silvia Fraga
authors.initials: SF
authors.lastname: Paveliu
references.citation: N Engl J Med. 2011 Dec 8;365(23):2151-3
references.pmid: 22150034
references.citation: BMC Health Serv Res. 2011 May 29;11:134
references.pmid: 21619706
references.citation: J Clin Epidemiol. 2002 Sep;55(9):945-50
references.pmid: 12393084
references.citation: Ann Pharmacother. 1993 Jul-Aug;27(7-8):832-40
references.pmid: 8364259
references.citation: Br J Clin Pharmacol. 2005 Dec;60(6):653-8
references.pmid: 16305591
references.citation: Drug Saf. 2010 Jul 1;33(7):e1-e23
references.pmid: 20553053
references.citation: Pharmacol Res. 1997 Feb;35(2):85-8
references.pmid: 9175573
references.citation: Diabetologia. 2006 Jan;49(1):1-6
references.pmid: 16362281
references.citation: Pharmacogenomics. 2003 Sep;4(5):647-55
references.pmid: 12943471
references.citation: Drug Saf. 2005;28(9):825-33
references.pmid: 16119975
references.citation: JAMA. 1998 Apr 15;279(15):1200-5
references.pmid: 9555760
references.citation: Arch Intern Med. 2005 Jun 27;165(12):1363-9
references.pmid: 15983284
references.citation: Br J Clin Pharmacol. 1996 May;41(5):434-5
references.pmid: 8735689
references.citation: Br J Clin Pharmacol. 1999 Oct;48(4):623-7
references.pmid: 10583035
references.citation: Eur J Intern Med. 2010 Oct;21(5):453-7
references.pmid: 20816604